Optimi Health

Optimi Health AAQS

The The AAQS of Optimi Health (OPTI.CN) as of Oct 16, 2026 is 3. In the previous year, The AAQS was 3.00 — a change of 0.00% (lower).

AAQS

3

YoY

0.00%

Last updated:

Optimi Health has a current AAQS of 3.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Optimi Health in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The Optimi Health AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2020
3.00 CAD
Jan 1, 2021
3.00 CAD
Jan 1, 2022
3.00 CAD
Jan 1, 2023
3.00 CAD
Jan 1, 2024
3.00 CAD
Jan 1, 2025
3.00 CAD
The Optimi Health AAQS history
YEARAAQSYoY
30.00%
30.00%
30.00%
30.00%
30.00%
3—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Optimi Health Stock analysis

What does Optimi Health do? Optimi Health Corp, with ticker OPTI.CN and ISIN CA68405H1001, is a company based in Vancouver, Canada. It has 9 employees and completed its IPO on February 25, 2021. The company's website is https://optimihealth.ca/. Optimi Health Corp is engaged in the development, cultivation, extraction, processing, and distribution of functional mushrooms. The company operates within the health and wellness sector, focusing on domestic and international markets. It provides drug and nutraceutical products to health food distributors, drug developers, and patients under Health Canada regulations. The company is licensed by Health Canada to produce and supply psychedelic substances, including MDMA, psilocybin, psilocin, and other psychedelic substances, both natural and synthetically formulated. Optimi Health Corp does not specify details about its manufacturing facilities, and no information is provided regarding the number of facilities or their technological specifications. The company's activities are centered on the production and distribution of functional mushrooms and psychedelic substances for health and wellness applications. Optimi Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Optimi Health stock

The AAQS of Optimi Health is 3 in 2025.

On Eulerpool you can find the complete historical development of The AAQS Optimi Health since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Optimi Health

All Key Metrics — Optimi Health